Send me a link:

*Text messaging rates may apply.

 Dow Down0.16% Nasdaq Up0.40%

Sunesis Pharmaceuticals, Inc. (SNSS)

-NasdaqCM
6.19 0.34(5.81%) Jul 23, 4:00PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Total Revenue 7,956   3,754   5,000  
Cost of Revenue -   -   -  
Gross Profit 7,956   3,754   5,000  
Operating Expenses
Research Development28,891  29,185  22,563  
Selling General and Administrative10,838  9,175  8,303  
Non Recurring -   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss (31,773) (34,606) (25,866)
Income from Continuing Operations
Total Other Income/Expenses Net92  (7,490)5,984  
Earnings Before Interest And Taxes(31,681)(42,096)(19,882)
Interest Expense2,917  1,855  259  
Income Before Tax(34,598)(43,951)(20,141)
Income Tax Expense -   -   -  
Minority Interest -   -   -  
Net Income From Continuing Ops(34,598)(43,951)(20,141)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (34,598) (43,951) (20,141)
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares (34,598) (43,951) (20,141)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.